Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.75 -0.90 (-24.66%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$2.70 -0.06 (-2.00%)
As of 03/28/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. STRR, BLAC, AEMD, OSRH, CTCX, NUWE, AMIX, CHEK, SINT, and GCTK

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Star Equity (STRR), Bellevue Life Sciences Acquisition (BLAC), Aethlon Medical (AEMD), OSR (OSRH), Carmell (CTCX), Nuwellis (NUWE), Autonomix Medical (AMIX), Check-Cap (CHEK), Sintx Technologies (SINT), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry.

Venus Concept vs.

Venus Concept (NASDAQ:VERO) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Star Equity has a net margin of -12.41% compared to Venus Concept's net margin of -74.62%. Venus Concept's return on equity of 0.00% beat Star Equity's return on equity.

Company Net Margins Return on Equity Return on Assets
Venus Concept-74.62% N/A -47.46%
Star Equity -12.41%-8.72%-4.62%

Venus Concept received 31 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.

CompanyUnderperformOutperform
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes

Star Equity has lower revenue, but higher earnings than Venus Concept. Star Equity is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$67.20M0.03-$37.25M-$88.23-0.03
Star Equity$53.36M0.15$25.13M-$3.91-0.64

Venus Concept has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500.

In the previous week, Star Equity had 5 more articles in the media than Venus Concept. MarketBeat recorded 10 mentions for Star Equity and 5 mentions for Venus Concept. Venus Concept's average media sentiment score of 0.18 beat Star Equity's score of 0.10 indicating that Venus Concept is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venus Concept
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Star Equity
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 49.0% of Venus Concept shares are owned by insiders. Comparatively, 33.5% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Venus Concept beats Star Equity on 8 of the 15 factors compared between the two stocks.

Remove Ads
Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.82M$4.35B$5.63B$7.84B
Dividend YieldN/A48.03%5.33%4.01%
P/E Ratio-0.3428.4223.5518.73
Price / Sales0.0349.26388.1990.75
Price / CashN/A51.0838.1734.64
Price / Book-1.136.116.894.23
Net Income-$37.25M$67.64M$3.20B$247.47M
7 Day Performance-11.29%-5.25%-3.06%-2.29%
1 Month Performance-18.14%-4.12%1.51%-5.81%
1 Year Performance-63.82%10.65%9.35%-0.94%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
0.6018 of 5 stars
$2.75
-24.7%
N/A-63.8%$1.81M$67.20M-0.34410Short Interest ↑
Gap Down
High Trading Volume
STRR
Star Equity
1.1784 of 5 stars
$2.20
+0.5%
N/A-43.2%$7.08M$50.38M-0.86460Analyst Revision
Positive News
Gap Up
BLAC
Bellevue Life Sciences Acquisition
N/A$1.44
-2.4%
N/A-77.5%$5.80MN/A0.00N/AHigh Trading Volume
AEMD
Aethlon Medical
2.918 of 5 stars
$0.38
+0.7%
$7.00
+1,760.7%
-78.2%$5.44M$570,000.00-0.2410Analyst Forecast
Short Interest ↓
News Coverage
OSRH
OSR
N/A$1.33
-7.3%
N/AN/A$5.38M$4.89B0.00N/ANews Coverage
Positive News
CTCX
Carmell
1.1081 of 5 stars
$0.25
-3.4%
N/A-95.2%$5.17M$32,839.000.0014Gap Down
NUWE
Nuwellis
3.6082 of 5 stars
$1.16
flat
$17.00
+1,365.5%
-92.2%$5.07M$8.74M-0.0170Short Interest ↓
AMIX
Autonomix Medical
3.5595 of 5 stars
$2.02
+8.9%
$28.00
+1,289.6%
-97.0%$4.96MN/A-0.161Short Interest ↓
CHEK
Check-Cap
1.0577 of 5 stars
$0.79
+2.3%
N/A-74.6%$4.51MN/A-0.2680Analyst Forecast
Short Interest ↓
Gap Down
SINT
Sintx Technologies
1.1301 of 5 stars
$3.12
-8.8%
N/A-72.0%$4.19M$1.64M-0.0640Short Interest ↓
Positive News
GCTK
GlucoTrack
1.8842 of 5 stars
$0.37
+1.9%
N/A-99.4%$3.87MN/A-0.015Short Interest ↓
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners